Reference
Ozawa Y, et al. Successful continuance of CDK4/6 inhibitor treatment with palbociclib after abemaciclib-induced hepatotoxicity in breast cancer: a case report. Anti-Cancer Drugs 35 : 89-92, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.1097/CAD.0000000000001529 [Summarised from an abstract]
Rights and permissions
About this article
Cite this article
Abemaciclib. Reactions Weekly 1989, 14 (2024). https://doi.org/10.1007/s40278-024-52160-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-52160-z